Much interest is now being focused on measurements of nitric oxide (NO) in exhaled air. In
healthy subjects exhaled NO seems to originate mainly in the nasal airways, whereas the …

Objective To determine possible changes in outcome from acute respiratory distress
syndrome (ARDS) and to compare severity of lung injury and methods of treatment from …

The vasodilator gas nitric oxide (NO) is produced in the paranasal sinuses and is excreted
continuously into the nasal airways of humans. This NO will normally reach the lungs with …

1. In healthy subjects, exhaled NO originates mainly from the upper airways with only a
minor contribution from the lower airways and the lungs. A large NO production takes place …

Because of its central role as a modulator of vasomotor tone and a mediator of inflammation,
NO has become a focus of intense investigation for clinicians and basic scientists interested …

Study objective To evaluate the percentage of nitric oxide (NO) responders in septic shock
patients with ARDS. Additionally, to investigate long-term NO effects on cardiac performance …

OBJECTIVE: To determine whether inhaled nitric oxide (NO) administered during
conventional mechanical ventilation could produce improvements in oxygenation and …

We investigated the response to varying concentrations of inhaled nitric oxide (NO) in 18
patients with acute respiratory distress syndrome (ARDS). The study was divided into two …

Inhaled nitric oxide is rapidly gaining popularity as a selective pulmonary vasodilator in
patients with acute lung injury and pulmonary hypertension. The development of nitric oxide …

Objective To evaluate the dose response of inhaled nitric oxide (NO) on gas exchange and
central haemodynamics in patients with early acute lung injury (ALI). Design Prospective …